BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 9, 2026
Home
»
Topics
»
Disease categories and therapies
» Endocrine/metabolic
Endocrine/metabolic
RSS
Pravastatin activates eNOS, provides additional clinical benefits
April 7, 1999
All rights to INFeD return to Schein
April 6, 1999
Regeneron and P&G initiate diabetes-associated obesity trial of Axokine
April 6, 1999
FDA approval granted for BioTime's blood plasma volume expander
April 6, 1999
Potent, orally active glucagon antagonist developed at Merck & Co.
April 6, 1999
Potent, selective human beta3-AR agonist characterized by Merck & Co.
April 6, 1999
Patent issued for new Merck glucagon antagonists
April 5, 1999
Inhibitors of the formation of AGTs described by Alteon
April 5, 1999
AMBI's Chromax demonstrates safety and efficacy in treatment of diabetes
April 5, 1999
Aradigm issued method patent for pulmonary insulin delivery
April 5, 1999
Previous
1
2
…
1645
1646
1647
1648
1649
1650
1651
1652
1653
…
1856
1857
Next
RSS